Catalyze: Product Definition for Small Molecules and Biologics - Preliminary Product/Lead Series Identification (R33 - Clinical Trial Not Allowed)
This funding opportunity supports early-stage research to develop new therapeutic agents for heart, lung, blood, and sleep disorders, specifically targeting projects that have identified promising small molecules or biologics ready for preclinical testing.
$350,000
Closed
Nationwide
Key Dates
Application Opens
January 24, 2022
Application Closes
November 21, 2024
Contact Information
Grantor
NIH OER Webmaster
Subscribe to view contact details
Newsletter Required
Categories
Health
